Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lymph Node Metastases: early-phase trial registry
2 of 2 indexed Lymph Node Metastases trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Lymph Node Metastases: 2 US clinical trials tracked, 2 recruiting.
Lymph Node Metastases is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University Medical Center Groningen, running 1 of these trials.
Enrollment posture brief
Registry condition lymph-node-metastases
OPEN 2 | RECR 100% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Lymph Node Metastases lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Lymph Node Metastases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Lymph Node Metastases is recruiting above its size-band peers.
2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Distribution of Lymph Node Metastases in Esophageal Carcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
NCT03222895
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
University Medical Center Groningen
NCT05076942
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Lymph Node Metastases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Lymph Node Metastases trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Lymph Node Metastases page
2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Lymph Node Metastases trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University Medical Center Groningen sponsors the most Lymph Node Metastases trials on record, review their full trial history before evaluating a specific study. See University Medical Center Groningen's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Lymph Node Metastases condition card totals 2 registered trials; most-linked intervention Radiotherapy combined with cisplatin; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.